Lv4
442 积分 2021-07-02 加入
Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents
17天前
已完结
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
18天前
已完结
Interrogating open issues in cancer precision medicine with patient-derived xenografts
24天前
已完结
Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
2个月前
已完结
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance
2个月前
已完结
Mutations linked to chemotherapy resistance in colorectal cancer
2个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
4个月前
已完结
皖公网安备34019202002308
